Technical Analysis for TLC - Taiwan Liposome Company, Ltd.

Grade Last Price % Change Price Change
grade F 5.94 -0.67% -0.04
TLC closed down 0.67 percent on Wednesday, February 20, 2019, on 7 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong N/A Down Down
See historical TLC trend table...

Date Alert Name Type % Chg
Feb 20 1,2,3 Pullback Bullish Bullish Swing Setup 0.00%
Feb 20 Narrow Range Bar Range Contraction 0.00%
Feb 20 NR7 Range Contraction 0.00%
Feb 19 Fell Below 50 DMA Bearish -0.67%
Feb 19 Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -0.67%
Feb 19 1,2,3 Pullback Bullish Bullish Swing Setup -0.67%
Feb 19 Boomer Buy Setup Bullish Swing Setup -0.67%
Feb 19 Narrow Range Bar Range Contraction -0.67%
Feb 19 Inside Day Range Contraction -0.67%
Feb 15 Crossed Above 50 DMA Bullish -4.35%

Older signals for TLC ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Taiwan Liposome Company, Ltd., a biopharmaceutical company, engages in the research, development, and commercialization of lipid-based pharmaceutical products. The company offers products in the areas of oncology, ophthalmology, peripheral arterial disease, fungal infection, anesthetic, and arthritis indications. Its products include Lipotecan, an anti-cancer camptothecin drug; Doxisome, a liposomal encapsulated formulation of doxorubicin; TLC178, a liposomal encapsulated formulation of vinorelbine; ProDex, an ophthalmic drug for the treatment of macular edema; ProFlow, an emulsion form of prostaglandin E1; AmBiL, a liposomal encapsulated formulation of amphotericin B; TLC198, a liposomal encapsulated bupivacaine, enabling the sustained release of a constant amount of local anesthetic; and TLC599, a corticosteroid encapsulated in lipid based drug delivery system for the treatment of inflammation caused by arthritis. The company was founded in 1997 and is headquartered in Taipei City, Taiwan.
Biopharmaceutical Drugs Inflammation Pharmacology Drug Delivery Arthritis Macular Edema Doxorubicin Peripheral Arterial Disease Amphotericin B Arbutus Biopharma Bupivacaine Liposome
Is TLC a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 2 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 11.0
52 Week Low 5.02
Average Volume 8,562
200-Day Moving Average 0.0
50-Day Moving Average 6.1989
20-Day Moving Average 6.2085
10-Day Moving Average 6.095
Average True Range 0.4497
ADX 40.67
+DI 26.0833
-DI 11.1713
Chandelier Exit (Long, 3 ATRs ) 6.4509
Chandelier Exit (Short, 3 ATRs ) 7.1491
Upper Bollinger Band 6.8398
Lower Bollinger Band 5.5772
Percent B (%b) 0.29
BandWidth 20.336635
MACD Line -0.1002
MACD Signal Line -0.074
MACD Histogram -0.0262
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 5.97
Resistance 3 (R3) 5.97 5.95 5.97
Resistance 2 (R2) 5.95 5.95 5.96 5.96
Resistance 1 (R1) 5.95 5.94 5.95 5.95 5.96
Pivot Point 5.93 5.93 5.94 5.94 5.93
Support 1 (S1) 5.93 5.93 5.93 5.93 5.92
Support 2 (S2) 5.91 5.92 5.92 5.92
Support 3 (S3) 5.91 5.91 5.92
Support 4 (S4) 5.91